ArticleKorean circulation journal2019

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation.

Hyunmee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.